Kiniksa Pharmaceuticals International, plc (KNSA) Current Ratio
- Current ratio · latest quarter: Value 3.79×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-03-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 3.79× | Current assets / current liabilities. $594.17M ÷ $156.61M ≈ 3.79× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 594.17M USD | Assets, Current |
| Current obligations | 156.61M USD | Liabilities, Current |
| Cash and equivalents | 189.95M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Debt Securities, Available-for-sale, Current |
| Customer receivables | 23.22M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 73.14M USD | Inventory, Net |
| Payables | 24.40M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $594.17M | $156.61M | $189.95M | (m) | $23.22M | $73.14M | $24.40M | (m) | 3.79× |
| 2025-12-31 | $527.18M | $139.18M | $165.60M | (m) | $15.59M | $54.90M | $2.03M | (m) | 3.79× |
| 2025-09-30 | $475.53M | $123.59M | $174.86M | (m) | $51.74M | $41.40M | $6.15M | (m) | 3.85× |
| 2025-06-30 | $420.31M | $117.83M | $192.04M | (m) | $31.91M | $48.18M | $8.96M | (m) | 3.57× |
| 2025-03-31 | $355.91M | $97.27M | $157.13M | (m) | $40.06M | $22.07M | $1.98M | (m) | 3.66× |
| 2024-12-31 | $331.80M | $100.62M | $183.58M | (m) | $41.72M | $26.36M | $2.04M | (m) | 3.30× |
| 2024-09-30 | $311.30M | $95.95M | $97.38M | (m) | $24.89M | $28.68M | $8.33M | (m) | 3.24× |
| 2024-06-30 | $301.02M | $84.29M | $99.27M | (m) | $20.45M | $34.86M | $7.39M | (m) | 3.57× |
| 2024-03-31 | $270.59M | $64.21M | $141.08M | $78.83M | $15.99M | $27.28M | $5.63M | (m) | 4.21× |
| 2023-12-31 | $276.30M | $63.67M | $107.95M | (m) | $21.27M | $31.12M | $8.25M | (m) | 4.34× |
| 2023-09-30 | $256.11M | $53.47M | $117.83M | $89.25M | $3.04M | $25.58M | $1.01M | (m) | 4.79× |
| 2023-06-30 | $246.04M | $47.47M | $112.57M | $88.67M | $24.65M | $23.96M | $648.00K | (m) | 5.18× |
| 2023-03-31 | $231.50M | $36.59M | $80.62M | $107.88M | $7.42M | $23.43M | $1.39M | (m) | 6.33× |
| 2022-12-31 | $243.06M | $47.07M | $122.72M | (m) | $12.66M | $21.60M | $7.90M | (m) | 5.16× |
| 2022-09-30 | $241.81M | $56.49M | $175.76M | (m) | $11.16M | $14.62M | $1.47M | (m) | 4.28× |
| 2022-06-30 | $179.94M | $43.54M | $94.31M | (m) | $7.81M | $19.92M | $2.52M | (m) | 4.13× |
| 2022-03-31 | $198.76M | $50.35M | $63.32M | (m) | $29.44M | $13.22M | $3.38M | (m) | 3.95× |
| 2021-12-31 | $196.45M | $44.82M | $122.47M | (m) | $3.98M | $3.67M | $1.87M | (m) | 4.38× |
| 2021-09-30 | $217.51M | $34.43M | $190.18M | (m) | $3.22M | $5.61M | $1.65M | (m) | 6.32× |
| 2021-06-30 | $244.81M | $38.78M | $167.95M | (m) | $2.55M | $6.38M | $4.16M | (m) | 6.31× |
| 2021-03-31 | $275.56M | $35.45M | $119.86M | (m) | (m) | $2.19M | $2.76M | (m) | 7.77× |
| 2020-12-31 | $333.25M | $31.85M | $114.04M | (m) | (m) | (m) | $503.00K | (m) | 10.46× |
| 2020-09-30 | $378.41M | $24.89M | $85.87M | (m) | (m) | (m) | $3.92M | (m) | 15.20× |
| 2020-06-30 | $264.49M | $20.55M | $123.46M | (m) | (m) | (m) | $2.37M | (m) | 12.87× |
| 2020-03-31 | $213.06M | $19.34M | $106.34M | (m) | (m) | (m) | $4.27M | (m) | 11.02× |
| 2019-12-31 | $241.63M | $27.83M | $46.93M | (m) | (m) | (m) | $5.69M | (m) | 8.68× |
| 2019-09-30 | $268.34M | $27.56M | $68.81M | (m) | (m) | (m) | $6.44M | (m) | 9.74× |
| 2019-06-30 | $296.46M | $30.18M | $82.81M | (m) | (m) | (m) | $9.34M | (m) | 9.82× |
| 2019-03-31 | $334.96M | $36.89M | $82.63M | (m) | (m) | (m) | $6.89M | (m) | 9.08× |
| 2018-12-31 | $313.75M | $42.55M | $71.98M | (m) | (m) | (m) | $10.92M | (m) | 7.37× |
| 2018-09-30 | $341.53M | $28.02M | $69.66M | (m) | (m) | (m) | $4.67M | (m) | 12.19× |
| 2018-06-30 | $363.87M | $23.14M | $285.52M | (m) | (m) | (m) | $561.00K | (m) | 15.72× |
| 2017-12-31 | $47.10M | $17.43M | $45.55M | $0.00 | (m) | (m) | $1.22M | (m) | 2.70× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.